Literature DB >> 812335

Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.

T Bergan, N Hoiby.   

Abstract

The simultaneously occurring mucoid (M) and non-mucoid (NM) variants of Pseudomonas aeruginosa frequently observed in cultures from the respiratory tract of chronically infected cystic fibrosis patients have been studied. M cultures in vitro were unstable and easily dissociated NM colonies. In a large proportion of the cases, M and NM variants occurring simultaneously in cultures from one and the same clinical specimen were of the same pyocine type, phage type, and serogroup. In some remaining cases there were small differences between the M and NM variants such that identity between the variants from one and the same specimen was possible, although not definite. The NM dissociants from M strains were of the same type as the M variant. The possible role of cross-infection and the interaction of bacteria and host response factors continuously tending to select the unstable M variant in vivo are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 812335

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand Suppl


  13 in total

1.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  High relatedness selects against hypermutability in bacterial metapopulations.

Authors:  Freya Harrison; Angus Buckling
Journal:  Proc Biol Sci       Date:  2007-05-22       Impact factor: 5.349

3.  Colonial dissociation and susceptibility to phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice.

Authors:  N M Kelly; J L Battershill; S Kuo; J P Arbuthnott; R E Hancock
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

4.  R-factor inheritance and plasmid content in mucoid Pseudomonas aeruginosa.

Authors:  S M Markowitz; F L Macrina; P V Phibbs
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

5.  Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.

Authors:  T W Seale; H Thirkill; M Tarpay; M Flux; O M Rennert
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

Review 6.  Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients.

Authors:  T B May; D Shinabarger; R Maharaj; J Kato; L Chu; J D DeVault; S Roychoudhury; N A Zielinski; A Berry; R K Rothmel
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

7.  Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay.

Authors:  L E Bryan; A Kureishi; H R Rabin
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

8.  Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains.

Authors:  B K Pugashetti; H M Metzger; L Vadas; D S Feingold
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

9.  Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.

Authors:  C Wolz; G Kiosz; J W Ogle; M L Vasil; U Schaad; K Botzenhart; G Döring
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

10.  Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients.

Authors:  D E Woods; J A Bass; W G Johanson; D C Straus
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.